Skip to main content

Day: September 27, 2022

Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.

CHICAGO and LOUGHBOROUGH, Sept. 27, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces that it has entered into a preliminary agreement with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry. The agreement covers the U.S. and all global sales and marketing of Nemaura’s Diabetes Management Solution, BEATdiabetes. The BEATdiabetes program is based on Nemaura’s noninvasive glucose monitoring solution, proBEAT. Nemaura and EVERSANA will work together to develop the optimal launch strategy for large-scale adoption of the diabetes management program, including franchising...

Continue reading

Teledyne introduces Contact Image Sensors for high-speed, high-resolution line scan imaging

Teledyne’s AxCIS Contact Image Sensor The new AxCIS is a high-speed, high-resolution line scan solution for space limited systemsWATERLOO, Ontario, Sept. 27, 2022 (GLOBE NEWSWIRE) — Teledyne DALSA is pleased to introduce AxCIS™, a new family of high-speed and high-resolution fully integrated line scan imaging modules. These easy-to-use Contact Image Sensors (CIS) combine sensors, lenses, and lights all-in-one, offering a lower cost inspection system for many demanding machine vision applications. AxCIS is powered by Teledyne’s new quadlinear CMOS image sensors, which deliver up to 120 kHz line rates for mono, 60 kHz x 3 for colour, at 900 dpi resolution, so that defects can be detected with unprecedented precision. Its unique staggered sensor design covers the whole field of view without missing pixels, providing a 100%...

Continue reading

Lifequest Partner, BPipe in the Philippines Enters Into an Agreement With a Major Global Food Company to Install a 10 m3/day Biopipe Biological Sewage Wastewater Treatment Plant

RIDGEFIELD PARK, NJ, Sept. 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – LIFEQUEST WORLD CORP (LQWC ) is focused on innovative, scalable and disruptive decentralized wastewater treatment and reuse technologies. Our flagship system is the Biopipe STP, which is a highly scalable onsite sludge, odor and chemical free sewage wastewater treatment technology. BPipe is an equity joint venture established in the Philippines to pursue both sewage and industrial wastewater treatment opportunities for technologies within our portfolio.   According to Mr. Freddie Canta, President of BPipe, “In addition to the sludge free, odor free, and chemical free features of Biopipe technology, the customizable design and flexibility to fit in small spaces were the deciding factors that led to this partnership with BPipe.  We are happy that this client...

Continue reading

Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv)

— Zai Lab Obtains Exclusive Rights to Develop and Commercialize TIVDAK, an FDA-approved First-in-Class Antibody-Drug Conjugate (ADC), in Mainland China, Hong Kong, Macau, and Taiwan — — Zai Lab will Leverage its Leadership in Women’s Cancer in China to Commercialize and Expand Patient Access to TIVDAK — — Collaboration Supports Regional Patient Enrollment for InnovaTV 301, a Global Phase 3 Trial of TIVDAK in Patients with Recurrent or Metastatic Cervical Cancer — SHANGHAI and CAMBRIDGE, Mass. and BOTHELL, Wash., Sept. 27, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage global biopharmaceutical company, and Seagen Inc. (Nasdaq: SGEN), a world leader and pioneer in antibody-drug conjugate (ADC) therapies today announced an exclusive...

Continue reading

Akari Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Pipeline Progress

Akari successfully closed a registered direct offering and concurrent private placement raising aggregate gross proceeds of approximately $12.8 million Financing supports Akari’s focused pipeline including the Phase 3 Part A clinical trial of nomacopan in severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) and the pre-clinical program developing long-acting PAS-nomacopan in geographic atrophy (GA) The Phase 3 Part A clinical trial of in severe pediatric HSCT-TMA remains on track for an expected data readout in the first half of 2023 Positive results from recent pre-clinical studies support the advancement of long-acting PAS-nomacopan toward IND/IMPD for clinical trials in GA and the potential to address significant unmet patient needsNEW YORK and LONDON, Sept. 27, 2022 (GLOBE NEWSWIRE)...

Continue reading

ProcessMaker Acquires Doculayer, Adding Next Generation Intelligent Document Processing (IDP) to its Business Process Management Portfolio

Acquisition brings best-in-breed AI/ML technology to ProcessMaker in order to further the company’s commitment to automate complex mission-critical processes for enterprise clients. Durham, NC, Sept. 27, 2022 (GLOBE NEWSWIRE) — Today, ProcessMaker, a worldwide leader in digital business transformation and process management, announces the acquisition of the intelligent document processing specialist Doculayer, based in Amsterdam, The Netherlands. Doculayer is known for its powerful, next-generation intelligent document processing solution. With this acquisition, ProcessMaker expands on its comprehensive approach to process orchestration and automation. This ensures organizations focused on operational excellence, compliance, and digital transformation initiatives can improve processes, speed up automation decisions, and increase...

Continue reading

Smart Transportation Market Size to Worth Around USD 206.80 Billion by 2028: Fortune Business Insights

According to Fortune Business Insights, the global smart transportation market size was valued at USD 92.48 billion in 2020. The market is expected to grow from USD 98.74 billion in 2021 to USD 206.80 billion, at CAGR of 11.1% over the forecast period of 2021 to 2028. Pune, India, Sept. 27, 2022 (GLOBE NEWSWIRE) — The global smart transportation market size to grow at CAGR of 11.1% during 2021 to 2028. Factors such as the increasing urban population, rising implementation of IoT-based technologies, and propagation of 5G-based communication enable the application of smart transportation infrastructure. The developed nations in the world have already executed the majority of the smart transportation plans as compared to the emerging economies. Smart Transportation Companies Analyzed in Report:IBM Corporation (New York, U.S.) Cisco...

Continue reading

Nootropics Market Size, Share, Growth & Trends [2022-2029] by Fortune Business Insights

Key Players in Nootropics Market are Purelife bioscience Co., Ltd., TruBrain, HVMN Inc., Peak Nootropics, AlternaScript HQ, SupNootropic bio co. Ltd, Accelerated Intelligence, Inc., Onnit Labs LLC, Clarity Nootropics, OptiMind Pune, India, Sept. 27, 2022 (GLOBE NEWSWIRE) — The nootropics market is anticipated to achievement traction from the increasing demand for smart drugs across the world. Nootropics are called intellectual enhancers are drugs that better the cognitive functions such as memory and learning in the human body. The report may cap several nootropics market trends, one being the rising preference towards supplements among individuals. The dual-trained neuroscientist and brain surgeon named Dr. Rahul Jandial in one of his interviews declared that nootropics are miracle brain drugs that helps us to boost brainpower. Nootropics...

Continue reading

Provident Financial Services, Inc. and Lakeland Bancorp, Inc. to Combine to Create New Jersey’s Premier Super-Community Banking Franchise

Creates top-tier New Jersey / Tri-State area super-community bank with significant scale Like-minded institutions that have shared visions, values, and a deep commitment to employees, customers and the community Strong capital base, low credit risk profile and experienced leadership team with M&A integration expertise provide significant advantages to navigate through the current economic environment ISELIN, N.J. and OAK RIDGE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) — Provident Financial Services, Inc. (NYSE: PFS) (“Provident”), the parent company of Provident Bank, and Lakeland Bancorp, Inc. (Nasdaq: LBAI) (“Lakeland”), the parent company of Lakeland Bank, today announced that they have entered into a definitive merger agreement pursuant to which the companies will combine in an all-stock merger, valued at approximately $1.3...

Continue reading

Provident Financial Services, Inc. and Lakeland Bancorp, Inc. to Combine to Create New Jersey’s Premier Super-Community Banking Franchise

Creates top-tier New Jersey / Tri-State area super-community bank with significant scale Like-minded institutions that have shared visions, values, and a deep commitment to employees, customers and the community Strong capital base, low credit risk profile and experienced leadership team with M&A integration expertise provide significant advantages to navigate through the current economic environment ISELIN and OAK RIDGE, NJ., Sept. 27, 2022 (GLOBE NEWSWIRE) —  Provident Financial Services, Inc. (NYSE: PFS) (“Provident”), the parent company of Provident Bank, and Lakeland Bancorp, Inc. (Nasdaq: LBAI) (“Lakeland”), the parent company of Lakeland Bank, today announced that they have entered into a definitive merger agreement pursuant to which the companies will combine in an all-stock merger, valued at approximately $1.3 billion....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.